⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Figure S4 from Evaluation of somatic mutations in urine samples as a non-invasive method for the detection and molecular classification of endometrial cancer

Laura Costas Irene Onieva Beatriz Pelegrina Fátima Marín Álvaro Carmona Marta López-Querol Jon Frias‐Gomez Paula Peremiquel‐Trillas José Manuel Martínez Eduard Dorca Joan Brunet Marta Pineda Jordi Ponce Xavier Matías‐Guiu Sílvia de Sanjosé F. Xavier Bosch Laia Alemany Sònia Paytubi

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

ROC curve showing the detection performance of the NGS test in supernatant urine samples

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Costas et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db643587522737 https://doi.org/10.1158/1078-0432.27033190

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S4 from Evaluation of somatic mutations in urine samples as a non-invasive method for the detection and molecular classification of endometrial cancer2024
2Supplementary Figure S5 from Evaluation of somatic mutations in urine samples as a non-invasive method for the detection and molecular classification of endometrial cancer2024
3Supplementary Figure S5 from Evaluation of somatic mutations in urine samples as a non-invasive method for the detection and molecular classification of endometrial cancer2024
4Supplementary Figure S1 from Evaluation of somatic mutations in urine samples as a non-invasive method for the detection and molecular classification of endometrial cancer2024
5Supplementary Figure S1 from Evaluation of somatic mutations in urine samples as a non-invasive method for the detection and molecular classification of endometrial cancer2024

Supplementary Figure S2 from Evaluation of somatic mutations in urine samples as a non-invasive method for the detection and molecular classification of endometrial cancer2024
Supplementary Figure S2 from Evaluation of somatic mutations in urine samples as a non-invasive method for the detection and molecular classification of endometrial cancer2024
Data from Evaluation of somatic mutations in urine samples as a non-invasive method for the detection and molecular classification of endometrial cancer2024